89 related articles for article (PubMed ID: 23240447)
1. Effect of quercetin-5'-sulfonic acid sodium salt on SOD activity and ADMA/DDAH pathway in extracorporeal liver perfusion in rats.
Trocha M; Merwid-Lad A; Szuba A; Sozański T; Magdalan J; Szelag A; Kopacz M; Kuźniar A; Nowak D
Adv Clin Exp Med; 2012; 21(4):423-31. PubMed ID: 23240447
[TBL] [Abstract][Full Text] [Related]
2. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
[TBL] [Abstract][Full Text] [Related]
3. Modulation of arginine and asymmetric dimethylarginine concentrations in liver and plasma by exogenous hydrogen sulfide in LPS-induced endotoxemia.
Bekpinar S; Develi-Is S; Unlucerci Y; Kusku-Kiraz Z; Uysal M; Gurdol F
Can J Physiol Pharmacol; 2013 Dec; 91(12):1071-5. PubMed ID: 24289078
[TBL] [Abstract][Full Text] [Related]
4. Effect of cyclophosphamide and morin-5'-sulfonic acid sodium salt, alone or in combination, on ADMA/DDAH pathway in rats.
Merwid-Ląd A; Trocha M; Chlebda-Sieragowska E; Sozański T; Magdalan J; Ksiądzyna D; Szuba A; Kopacz M; Kuźniar A; Nowak D; Pieśniewska M; Fereniec-Gołębiewska L; Szeląg A
Pharmacol Rep; 2013; 65(1):201-7. PubMed ID: 23563039
[TBL] [Abstract][Full Text] [Related]
5. The impact of sitagliptin, inhibitor of dipeptidyl peptidase-4 (DPP-4), on the ADMA-DDAH-NO pathway in ischemic and reperfused rat livers.
Trocha M; Nowak B; Merwid-Ląd A; Szuba A; Dzięgiel P; Pieśniewska M; Gomułkiewicz A; Wiśniewski J; Piasecki T; Gziut M; Szeląg A; Sozański T
Adv Clin Exp Med; 2018 Nov; 27(11):1483-1490. PubMed ID: 30303311
[TBL] [Abstract][Full Text] [Related]
6. GC-MS assay for hepatic DDAH activity in diabetic and non-diabetic rats by measuring dimethylamine (DMA) formed from asymmetric dimethylarginine (ADMA): evaluation of the importance of S-nitrosothiols as inhibitors of DDAH activity in vitro and in vivo in humans.
Chobanyan K; Thum T; Suchy MT; Zhu B; Mitschke A; Gutzki FM; Beckmann B; Stichtenoth DO; Tsikas D
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):32-41. PubMed ID: 17825631
[TBL] [Abstract][Full Text] [Related]
7. Influence of ezetimibe on ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
Trocha M; Merwid-Ląd A; Sozański T; Ewa Chlebda-Sieragowska E; Szuba A; Dzięgiel P; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Gomułkiewicz A; Cwynar-Zając Ł; Brykner R; Szeląg A
Pharmacol Rep; 2013; 65(1):122-33. PubMed ID: 23563030
[TBL] [Abstract][Full Text] [Related]
8. Role of dimethylarginine dimethylaminohydrolase activity in regulation of tissue and plasma concentrations of asymmetric dimethylarginine in an animal model of prolonged critical illness.
Davids M; Richir MC; Visser M; Ellger B; van den Berghe G; van Leeuwen PA; Teerlink T
Metabolism; 2012 Apr; 61(4):482-90. PubMed ID: 22000584
[TBL] [Abstract][Full Text] [Related]
9. Influence of water-soluble flavonoids, quercetin-5'-sulfonic acid sodium salt and morin-5'-sulfonic acid sodium salt, on antioxidant parameters in the subacute cadmium intoxication mouse model.
Chlebda E; Magdalan J; Merwid-Lad A; Trocha M; Kopacz M; Kuźniar A; Nowak D; Szelag A
Exp Toxicol Pathol; 2010 Mar; 62(2):105-8. PubMed ID: 19297139
[TBL] [Abstract][Full Text] [Related]
10. The protection by heme oxygenase-1 induction against thioacetamide-induced liver toxicity is associated with changes in arginine and asymmetric dimethylarginine.
Develi-Is S; Bekpinar S; Kalaz EB; Evran B; Unlucerci Y; Gulluoglu M; Uysal M
Cell Biochem Funct; 2013 Mar; 31(2):122-8. PubMed ID: 22886620
[TBL] [Abstract][Full Text] [Related]
11. Antidiabetic drug metformin is effective on the metabolism of asymmetric dimethylarginine in experimental liver injury.
Bal F; Bekpinar S; Unlucerci Y; Kusku-Kiraz Z; Önder S; Uysal M; Gurdol F
Diabetes Res Clin Pract; 2014 Nov; 106(2):295-302. PubMed ID: 25263501
[TBL] [Abstract][Full Text] [Related]
12. Assessment of efficacy of quercetin-5'-sulfonic acid sodium salt in the treatment of acute chromium poisoning: experimental studies.
Szelag A; Magdalan J; Kopacz M; Kuźniar A; Kowalski P; Pieśniewska M
Pol J Pharmacol; 2003; 55(6):1097-103. PubMed ID: 14730106
[TBL] [Abstract][Full Text] [Related]
13. Changes in ADMA/DDAH pathway after hepatic ischemia/reperfusion injury in rats: the role of bile.
Ferrigno A; Rizzo V; Bianchi A; Di Pasqua LG; Berardo C; Richelmi P; Vairetti M
Biomed Res Int; 2014; 2014():627434. PubMed ID: 25243167
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide upregulates dimethylarginine dimethylaminohydrolase-2 via cyclic GMP induction in endothelial cells.
Sakurada M; Shichiri M; Imamura M; Azuma H; Hirata Y
Hypertension; 2008 Nov; 52(5):903-9. PubMed ID: 18824664
[TBL] [Abstract][Full Text] [Related]
15. Dimethylarginine dimethylaminohydrolase inhibition and asymmetric dimethylarginine accumulation contribute to endothelial dysfunction in rats exposed to glycosylated protein: effects of aminoguanidine.
Yin QF; Fu SH; He P; Xiong Y
Atherosclerosis; 2007 Jan; 190(1):53-61. PubMed ID: 16533509
[TBL] [Abstract][Full Text] [Related]
16. Changes in Biliary Levels of Arginine and its Methylated Derivatives after Hepatic Ischaemia/Reperfusion.
Ferrigno A; Di Pasqua LG; Berardo C; Rizzo V; Richelmi P; Vairetti M
Basic Clin Pharmacol Toxicol; 2016 Jul; 119(1):101-9. PubMed ID: 26663642
[TBL] [Abstract][Full Text] [Related]
17. Severely decreased activity of placental dimethylarginine dimethylaminohydrolase in pre-eclampsia.
Anderssohn M; Maass LM; Diemert A; Lüneburg N; Atzler D; Hecher K; Böger RH
Eur J Obstet Gynecol Reprod Biol; 2012 Apr; 161(2):152-6. PubMed ID: 22285683
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease.
Matsuguma K; Ueda S; Yamagishi S; Matsumoto Y; Kaneyuki U; Shibata R; Fujimura T; Matsuoka H; Kimoto M; Kato S; Imaizumi T; Okuda S
J Am Soc Nephrol; 2006 Aug; 17(8):2176-83. PubMed ID: 16807406
[TBL] [Abstract][Full Text] [Related]
19. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
Feng M; Liu L; Guo Z; Xiong Y
Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of resveratrol derivative BTM-0512 on high glucose-induced cell senescence involves dimethylaminohydrolase/asymmetric dimethylarginine pathway.
Yuan Q; Peng J; Liu SY; Wang CJ; Xiang DX; Xiong XM; Hu CP; Li YJ
Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):630-5. PubMed ID: 20132235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
